Tradipitant: A Novel NK-1 Receptor Antagonist for the Management of Motion Sickness- A New Era in Drug Development. (2026). International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). https://doi.org/10.33974/xxyc9n51